These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6751623)

  • 1. [Effect of insulin treatment on insulin secretion and insulin resistance in obese type II diabetics].
    Hidaka H
    Horumon To Rinsho; 1982 Jul; 30(7):699-704. PubMed ID: 6751623
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics.
    Hidaka H; Nagulesparan M; Klimes I; Clark R; Sasaki H; Aronoff SL; Vasquez B; Rubenstein AH; Unger RH
    J Clin Endocrinol Metab; 1982 Feb; 54(2):217-22. PubMed ID: 7033272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
    Duman BS; Turkoglu C; Gunay D; Cagatay P; Demiroglu C; Buyukdevrim AS
    Diabetes Nutr Metab; 2003 Aug; 16(4):243-50. PubMed ID: 14768774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].
    Guy-Grand B; Bour H
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):81-92. PubMed ID: 4606004
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin secretion in insulin-requiring diabetics before and during insulin treatment.
    Enk B
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):559-70. PubMed ID: 577340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide response to arginine infusion in insulin requiring diabetics.
    Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
    Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Does insulin resistance present a significant problem in type 2 diabetes?].
    Glaser B; Leibovitch G; Nesher R; Cerasi E
    Harefuah; 1986 Nov; 111(10):330-3. PubMed ID: 3546012
    [No Abstract]   [Full Text] [Related]  

  • 8. Obesity and insulin resistance in Swedish subjects.
    Arner P
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S85-6. PubMed ID: 8894488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pharmacologic approaches to the treatment of diabetes.
    Johnson DG; Bressler R
    Spec Top Endocrinol Metab; 1984; 6():163-92. PubMed ID: 6151747
    [No Abstract]   [Full Text] [Related]  

  • 11. The biological role of islet amyloid polypeptide (amylin) in diabetes: some recent results.
    Sandler S
    Diabetologia; 1994 Feb; 37(2):225-6. PubMed ID: 8163061
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin secretion, insulin resistance, and obesity.
    DeFronzo RA
    Int J Obes; 1982; 6 Suppl 1():73-82. PubMed ID: 6749725
    [No Abstract]   [Full Text] [Related]  

  • 13. [Respective roles of insulin resistance and disorders of secretion of this hormone in the non-insulin-dependent diabetic].
    Vague P
    Journ Annu Diabetol Hotel Dieu; 1982; ():7-17. PubMed ID: 7047844
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin resistance in diabetes in the obese subject].
    Denard Y; Darnaud J; Barousse C; Navez I
    Journ Annu Diabetol Hotel Dieu; 1984; ():137-49. PubMed ID: 6399530
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evidence of a reduction of insulin secretion in diabetes with or without obesity. Discussion of the therapeutic use of biguanides].
    Luyckx A; Lefebvre P
    Ann Endocrinol (Paris); 1969; 30(6):717-30. PubMed ID: 5384987
    [No Abstract]   [Full Text] [Related]  

  • 16. Two forms of insulin resistance.
    Thompson WC; Shields GW; Crofford OB
    J Tenn Med Assoc; 1982 Oct; 75(10):678-82. PubMed ID: 6757584
    [No Abstract]   [Full Text] [Related]  

  • 17. [HLA antigens, hormonal profile and insulin antibodies in insulin-dependent diabetes mellitus with retinopathy].
    Vasiukova EA; Guliaeva ES; Kantsel'son LA; Kniazev IuA; Mikhaĭlova NA
    Klin Med (Mosk); 1981 Nov; 59(11):42-6. PubMed ID: 7033655
    [No Abstract]   [Full Text] [Related]  

  • 18. Combinations of oral hypoglycemic drugs in obese, insulin-resistant diabetics.
    Fineberg SK
    Geriatrics; 1968 Sep; 23(9):137-46. PubMed ID: 5673663
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The natural history of diabetes with respect to disorders of insulin function].
    Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
    Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.